Radiomic features at contrast-enhanced CT predict proliferative hepatocellular carcinoma and its prognosis after transarterial chemoembolization
Abstract Proliferative hepatocellular carcinoma (HCC) is an aggressive phenotype associated with unfavorable clinical outcomes. Predicting the preoperative subtype of HCC can aid in the development of individualized treatment. We retrospectively recruited 180 HCC patients who underwent hepatic resec...
Saved in:
| Main Authors: | Haifeng He, Zhichao Feng, Junhong Duan, Wenzhi Deng, Zuowei Wu, Yizi He, Qi Liang, Yongzhi Xie |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-03-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-94684-w |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Defining a radiomics feature selection method for predicting response to transarterial chemoembolization in hepatocellular carcinoma patients
by: Helen Zhang, et al.
Published: (2024-03-01) -
TRACE Model: Predicting Treatment Response to Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma
by: Wang W, et al.
Published: (2025-01-01) -
Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
by: You-Bin Wang, et al.
Published: (2023-09-01) -
Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
by: B. I. Dolgushin, et al.
Published: (2016-09-01) -
Transarterial chemoembolization in hepatocellular carcinoma treatment during the COVID-19 pandemic
by: Filipović Aleksandar, et al.
Published: (2024-01-01)